Epidemiological monitoring of testicular germ cell tumor incidence, mortality, and registration accuracy
- 作者: Emelyanov V.N.1,2, Kuzin A.A.1, Panin I.S.1, Kulemin M.E.1
-
隶属关系:
- Kirov Military Medical Academy
- Saint Petersburg Medical and Social Institute
- 期: 卷 27, 编号 1 (2025)
- 页面: 115-124
- 栏目: Review
- URL: https://journals.rcsi.science/1682-7392/article/view/292170
- DOI: https://doi.org/10.17816/brmma632060
- ID: 292170
如何引用文章
详细
This study analyzed the epidemiological trends of testicular germ cell tumors (TGCTs) worldwide, as well as the potential factors influencing incidence, mortality, and registration accuracy between 2010 and 2020. Data sources included databases from the Russian Ministry of Health; biomedical research platforms such as PubMed, UpToDate, eLibrary, and Scopus; and systematic and semantic search methods for epidemiological data analysis. Historical epidemiological data show a continuous increase in TGCT incidence worldwide, with a tendency toward stabilization in high-incidence countries and a rising trend in historically low-incidence regions. Despite high TGCT incidence rates in Western and Northern Europe, mortality remains relatively low, demonstrating the effectiveness of early detection and treatment strategies. Geographical variations in TGCT incidence indicate a potential role of genetic and/or environmental factors in influencing the risk of this malignancy. Negative epidemiological trends may be associated with increase in etiological factors, the implementation of early detection programs, and population migration from high-incidence to low-incidence areas. Notably, historically high-TGCT-incidence regions (i.e., Western Europe, Northern Europe, Australia, and New Zealand) have shown stabilization, whereas historically low-TGCT-incidence regions (Central Africa, Asia) have experienced a rising trend. The mechanisms underlying these geographic and temporal variations remain unclear. However, considering the increasing global incidence of TGCTs, further advancements in diagnostic methods and treatment strategies are warranted. Such improvements will contribute to mortality reduction and enhance early detection of this malignancy.
作者简介
Vadim N. Emelyanov
Kirov Military Medical Academy; Saint Petersburg Medical and Social Institute
编辑信件的主要联系方式.
Email: vmeda-nio@mil.ru
ORCID iD: 0009-0002-2798-1518
SPIN 代码: 1239-5721
MD, Cand. Sci. (Medicine)
俄罗斯联邦, Saint Petersburg; Saint PetersburgAlexandr A. Kuzin
Kirov Military Medical Academy
Email: vmeda-nio@mil.ru
ORCID iD: 0000-0001-9154-7017
SPIN 代码: 6220-1218
MD, Dr. Sci. (Medicine), Professor
俄罗斯联邦, Saint PetersburgIvan S. Panin
Kirov Military Medical Academy
Email: vmeda-nio@mil.ru
ORCID iD: 0009-0000-5460-5652
SPIN 代码: 5830-9330
俄罗斯联邦, Saint Petersburg
Maxim E. Kulemin
Kirov Military Medical Academy
Email: vmeda-nio@mil.ru
ORCID iD: 0000-0002-0102-4413
SPIN 代码: 9470-7404
俄罗斯联邦, Saint Petersburg
参考
- Bray F., Colombet M., Mery L., et al., editors. Cancer incidence in five continents. Vol. XI. Lyon: International Agency for Research on Cancer; 2021.
- Merabishvili VM; Belyaev AM, Shcherbakov AM, editors. Malignant neoplasms in the North-Western federal district of Russia (morbidity, mortality, reliability of accounting, survival of patients). Express-information. Five issue. Saint Petersburg; 2020. 236 p. (In Russ.)
- Gillessen S, Sauve N, Collette L, et al. Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): results from the IGCCCG update consortium. J Clin Oncol. 2021;39(14):1563–1574. EDN: ZHHFZI doi: 10.1200/JCO.20.03296
- Beyer J, Collette L, Sauvé N, et al. Survival and new prognosticators in metastatic seminoma: results from the IGCCCG-update consortium. J Clin Oncol. 2021;39(14):1553–1562. doi: 10.1002/1097-0142(195807/08)11
- Grumet RF, Macmahon B. Trends in mortality from testicular neoplasms. Cancer. 1958;11(4):790–797. doi: 10.1002/1097-0142(195807/08)11:4<790::aid-cncr2820110417>3.0.co;2-f
- Clemmesen J. Doubling of the incidence of testicular carcinoma in Copenhagen, 1943–1962. Acta Pathol Microbiol Scand. 1968;72(2):348–349. doi: 10.1111/j.1699-0463.1968.tb01350.x
- Purdue MP, Devesa SS, Sigurdson AJ, et al. International patterns and trends in testis cancer incidence. Int J Cancer. 2005;115(5): 822–827. doi: 10.1002/ijc.20931
- Chia VM, Quraishi SM, Devesa SS, et al. International trends in testicular cancer incidence, 1973–2002. Cancer Epidemiol Biomarkers Prev. 2010;19(5):1151–1159. doi: 10.1158/1055-9965.EPI-10-0031
- Znaor A, Lortet-Tieulent J, Jemal A, et al. International variations and trends in testicular cancer incidence and mortality. Eur Urol. 2014;65(6):1095–1096. doi: 10.1016/j.eururo.2013.11.004
- Moch H, Humphrey PA, Ulbright TM, et al editors. WHO classification of tumours of the urinary system and male genital organs. 4th ed. World health Organization; 2016. doi: 10.1016/j.eururo.2016.02.029
- Ferlay J., Colombet M., Soerjomataram I., et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–387. doi: 10.1016/j.ejca.2018.07.005
- Kaprin AD, Starinsky VV, Shakhzadova AO, editors. Malignant neoplasms in Russia in 2020 (morbidity and mortality). Moscow: Moscow Research Institute of Oncology named after P.A. Herzen; 2021. 252 р. (In Russ.)
- Bray F, Richiardi L, Ekbom A. Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer. 2006;118(12): 3099–3111. doi: 10.1002/ijc.21747
- Tandstad T, Kollmannsberger CK, Roth BJ, et al. Practice makes perfect: the rest of the story in testicular cancer as a model curable neoplasm. J Clin Oncol. 2017;35(31):3525–3528. doi: 10.1200/JCO.2017.73.4723
- Merabishvili VM. Medical-statistical terminological glossary: methodological manual for physicians, residents, graduate students and researchers. Saint Petersburg; 2018. (In Russ.)
- Merabishvili VM. List of reasons for changing the system of state reporting of oncological service. Problems in oncology. 2018;64(3):445–452. EDN: XWBIFV doi: 10.37469/0507-3758-2018-64-3-445-452
- Merabishvili VM. The index of reliability of accounting is the most important criterion for an objective assessment of the activity of the oncological service for all localizations of malignant neoplasms, regardless of the level of mortality of patients. Problems in oncology. 2019;65(4):510–515. EDN: BEYUYG doi: 10.37469/0507-3758-2019-65-4-510-515
- Gurney JK, Florio AA, Znaor A, et. al. International trends in the incidence of testicular cancer: lessons from 35 years and 41 countries. Eur Urol. 2019;76(5):615–623. doi: 10.1016/j.eururo.2019.07.002
- Trabert B, Chen J, Devesa SS, et. al. International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973–2007. Andrology. 2015;3(1):4–12. doi: 10.1111/andr.293
- Trama A, Foschi R, Larrañaga N, et. al. Survival of male genital cancers (prostate, testis and penis) in Europe 1999–2007: results from the EUROCARE-5 study. Eur J Cancer. 2015;51(15):2206–2216. doi: 10.1016/j.ejca.2015.07.027
- Stang A, Jansen L, Trabert B, et. al. Survival after a diagnosis of testicular germ cell cancers in Germany and the United States, 2002–2006: a high resolution study by histology and age. Cancer Epidemiol. 2013;37(4):492–497. doi: 10.1016/j.canep.2013.03.017
- Nettersheim D, Schorle H. The plasticity of germ cell cancers and its dependence on the cellular microenvironment. J Cell Mol Med. 2017;21(8):1463–1467. doi: 10.1111/jcmm.13082
- Curreri SA, Fung C, Beard CJ. Secondary malignant neoplasms in testicular cancer survivors. Urol Oncol. 2015;33(9):392–398. doi: 10.1016/j.urolonc.2015.05.002
- Groot HJ, Lubberts S, de Wit R, et. al. Risk of solid cancer after treatment of testicular germ cell cancer in the platinum era. J Clin Oncol. 2018;36(24):2504–2513. doi: 10.1200/JCO.2017.77.4174
- Nicu AT, Medar C, Chifiriuc MC, et al. Epigenetics and testicular cancer: bridging the gap between fundamental biology and patient care. Front Cell Dev Biol. 2022;10:861995. EDN: UOINIU doi: 10.3389/fcell.2022.861995
- Litchfield K, Shipley J, Turnbull C. Common variants identified in genome-wide association studies of testicular germ cell tumour: an update, biological insights and clinical application. Andrology. 2015;3(1):34–46. EDN: UPHHHD doi: 10.1111/andr.304
- Dong C., Hemminki K. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer. 2001. 2001;92(1):144–150. doi: 10.1002/1097-0215
补充文件
